Cargando…
Liquid biopsies and minimal residual disease in lymphoid malignancies
Minimal residual disease (MRD) assessment using peripheral blood instead of bone marrow aspirate/biopsy specimen or the biopsy of the cancerous infiltrated by lymphoid malignancies is an emerging technique with enormous interest of research and technological innovation at the current time. In some l...
Autores principales: | Bou Zerdan, Maroun, Kassab, Joseph, Saba, Ludovic, Haroun, Elio, Bou Zerdan, Morgan, Allam, Sabine, Nasr, Lewis, Macaron, Walid, Mammadli, Mahinbanu, Abou Moussa, Sarah, Chaulagain, Chakra P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203459/ https://www.ncbi.nlm.nih.gov/pubmed/37228488 http://dx.doi.org/10.3389/fonc.2023.1173701 |
Ejemplares similares
-
Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023) -
Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022) -
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy
por: Bou Zerdan, Maroun, et al.
Publicado: (2022) -
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022) -
Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature
por: Zerdan, Maroun Bou, et al.
Publicado: (2021)